P59 | IMMUNOHISTOCHEMISTRY ANALYSIS TO DETECT A MOLECULAR SIGNATURE IN INTERVERTEBRAL DISC DEGENERATION

Intervertebral disc degeneration (IDD) is known as a primary contributor to low back pain, a debilitating condition which is the leading cause of disability worldwide. Traditionally, its evaluation is based exclusively on clinical parameters including MRI. Evidence to date shows that patients with...

Full description

Saved in:
Bibliographic Details
Format: Article
Language:English
Published: PAGEPress Publications 2025-08-01
Series:European Journal of Histochemistry
Subjects:
-
Online Access:https://www.ejh.it/ejh/article/view/4384
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849227353706725376
collection DOAJ
description Intervertebral disc degeneration (IDD) is known as a primary contributor to low back pain, a debilitating condition which is the leading cause of disability worldwide. Traditionally, its evaluation is based exclusively on clinical parameters including MRI. Evidence to date shows that patients with similar radiological findings may have significantly different prognoses, suggesting that additional factors influence the outcome of IDD. These factors may include genetic predisposition, lifestyle, comorbidities1, and the role of “protein sensors” whose expression and activity can promote cell protection. To try to resolve this discrepancy and understand the variability in disease progression and response to treatment, research is focusing on patient-specific biomarkers and risk factors. With this in mind, we conducted a study on IVD biopsies from 40 patients with mild IVD degeneration (Pfirrmann grade III) undergoing discectomy, in order to identify a molecular signature correlating with clinical parameters. Immunohisto-chemistry focused on the expression of specific proteins belonging to different potentially informative signaling: the transcription factors FOXO3a, HIF1α, BRY, the enzyme superoxide dismutase-2, and the glucose transporter GLUT1. Cross-sectional analysis showed that all these proteins may be considered stable biomarkers of IDD. However, no significant differences in their expression were found based on sex, age, smoking status, BMI, duration of symptoms prior to surgery, inflammatory cell density or surgical site. Post-surgical follow-up (n=24) showed healing in 75% of cases, although 62.5% had inflammation and 25% relapses: this means that the IVD cannot be said to be fully healed from a cellular and molecular point of view, due to associated pathobiological changes, causing recurrent symptoms. Consistently, no statistically significant differences were observed in the expression of the proteins under investigation. Our approach to biomarker discovery is just beginning and requires examining other pathways and enlarging the group of patients also comparing different grades of disease.
format Article
id doaj-art-415f1ebe7e614e77aa45adb1fcf4e282
institution Kabale University
issn 1121-760X
2038-8306
language English
publishDate 2025-08-01
publisher PAGEPress Publications
record_format Article
series European Journal of Histochemistry
spelling doaj-art-415f1ebe7e614e77aa45adb1fcf4e2822025-08-23T11:18:38ZengPAGEPress PublicationsEuropean Journal of Histochemistry1121-760X2038-83062025-08-0169s210.4081/ejh.2025.4384P59 | IMMUNOHISTOCHEMISTRY ANALYSIS TO DETECT A MOLECULAR SIGNATURE IN INTERVERTEBRAL DISC DEGENERATION Intervertebral disc degeneration (IDD) is known as a primary contributor to low back pain, a debilitating condition which is the leading cause of disability worldwide. Traditionally, its evaluation is based exclusively on clinical parameters including MRI. Evidence to date shows that patients with similar radiological findings may have significantly different prognoses, suggesting that additional factors influence the outcome of IDD. These factors may include genetic predisposition, lifestyle, comorbidities1, and the role of “protein sensors” whose expression and activity can promote cell protection. To try to resolve this discrepancy and understand the variability in disease progression and response to treatment, research is focusing on patient-specific biomarkers and risk factors. With this in mind, we conducted a study on IVD biopsies from 40 patients with mild IVD degeneration (Pfirrmann grade III) undergoing discectomy, in order to identify a molecular signature correlating with clinical parameters. Immunohisto-chemistry focused on the expression of specific proteins belonging to different potentially informative signaling: the transcription factors FOXO3a, HIF1α, BRY, the enzyme superoxide dismutase-2, and the glucose transporter GLUT1. Cross-sectional analysis showed that all these proteins may be considered stable biomarkers of IDD. However, no significant differences in their expression were found based on sex, age, smoking status, BMI, duration of symptoms prior to surgery, inflammatory cell density or surgical site. Post-surgical follow-up (n=24) showed healing in 75% of cases, although 62.5% had inflammation and 25% relapses: this means that the IVD cannot be said to be fully healed from a cellular and molecular point of view, due to associated pathobiological changes, causing recurrent symptoms. Consistently, no statistically significant differences were observed in the expression of the proteins under investigation. Our approach to biomarker discovery is just beginning and requires examining other pathways and enlarging the group of patients also comparing different grades of disease. https://www.ejh.it/ejh/article/view/4384-
spellingShingle P59 | IMMUNOHISTOCHEMISTRY ANALYSIS TO DETECT A MOLECULAR SIGNATURE IN INTERVERTEBRAL DISC DEGENERATION
European Journal of Histochemistry
-
title P59 | IMMUNOHISTOCHEMISTRY ANALYSIS TO DETECT A MOLECULAR SIGNATURE IN INTERVERTEBRAL DISC DEGENERATION
title_full P59 | IMMUNOHISTOCHEMISTRY ANALYSIS TO DETECT A MOLECULAR SIGNATURE IN INTERVERTEBRAL DISC DEGENERATION
title_fullStr P59 | IMMUNOHISTOCHEMISTRY ANALYSIS TO DETECT A MOLECULAR SIGNATURE IN INTERVERTEBRAL DISC DEGENERATION
title_full_unstemmed P59 | IMMUNOHISTOCHEMISTRY ANALYSIS TO DETECT A MOLECULAR SIGNATURE IN INTERVERTEBRAL DISC DEGENERATION
title_short P59 | IMMUNOHISTOCHEMISTRY ANALYSIS TO DETECT A MOLECULAR SIGNATURE IN INTERVERTEBRAL DISC DEGENERATION
title_sort p59 immunohistochemistry analysis to detect a molecular signature in intervertebral disc degeneration
topic -
url https://www.ejh.it/ejh/article/view/4384